Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Glucagon-like peptide 2 (GLP-2) is intestinotrophic, antisecretory, and transit-modulating in rodents, and it is mainly secreted from the intestinal mucosa of the terminal ileum and colon after food ingestion. We assessed the effect of GLP-2 on the gastrointestinal function in patients without a terminal ileum and colon who have functional short-bowel syndrome with severe malabsorption of wet weight (>1.5 kg/day) and energy (>2.3 MJ/day) and no postprandial secretion of GLP-2.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Gastroenterology |
Vol/bind | 120 |
Udgave nummer | 4 |
Sider (fra-til) | 806-815 |
Antal sider | 10 |
ISSN | 0016-5085 |
Status | Udgivet - mar. 2001 |
ID: 168197